Derangements of pyruvate dehydrogenase in circulating lymphocytes of NIDDM patients and their healthy offspring

Journal of Endocrinological Investigation

Volumn 22, Issue 7, 1999, Pages 519-526

  Mostert, M ^a   Rabbone, I ^a   Piccinini, M ^a   Curto, M ^a   Vai, S ^a   Musso, A ^a   Rinaudo, M T ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Sezione di Biochimica   (Italy)

Author keywords

Circulating lymphocytes; Offspring of NIDDM patients; Pyruvate dehydrogenase

Indexed keywords

INSULIN; PYRUVATE DEHYDROGENASE;

ADULT; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LYMPHOCYTE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PROGENY;

EID: 0032861432     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343603     Document Type: Article

References (43)

1. Rinaudo M.T., Curto M., Rabbone I., Piccinini M., Bruno R., Mioletti S., Gamba S. Effect of sulfonylurea agents on pyruvate dehydrogenase activity in circulating lymphocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM). J. Diab. Comp. 1994, 8: 221-225.
2. Curto M., Novi R.F., Rabbone I., Maurino M., Piccinini M., Mioletti S., Mostert M., Bruno R., Rinaudo M.T. Insulin resistance in obese subjects and newly diagnosed NIDDM patients and derangements of pyruvate dehydrogenase in their circulating lymphocytes. Int. J. Obes. 1997, 21: 1137-1142.
3. Froguel P., Velho G., Cohen D., Passa P. Strategy for the collection of sibling-pair data for genetic studies in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991, 34: 658.
4. Wieland O.H. The mammalian pyruvate dehydrogenase complex: Structure and regulation. Rev. Physiol. Biochem. Pharmacol. 1983, 96: 123-170.
5. Wieland O.H., Patzelt C., Löffler G. Active and inactive forms of pyruvate dehydrogenase in rat liver. Effect of starvation and refeeding and of insulin treatment on pyruvate dehydrogenase interconversion. Eur. J. Biochem. 1972, 26: 426-433.
6. Wieland O.H., Siess E., Schulze-Wethmar F.H., Von Funcke H.G., Winton B. Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney. Effect of diabetes, fasting, and refeeding on pyruvate dehydrogenase interconversion. Arch. Biochem. Biophys. 1971, 143: 593-601.
7. Stansbie D., Denton R.M., Bridges B.J., Pask H. T., Randle P.J. Regulation of pyruvate dehydrogenase and pyruvate dehydrogenase phosphate phosphatase activity in rat epididymal fat-pads. Biochem. J. 1976, 154: 225-236.
8. Hughes W.A., Denton R.M. Incorporation of 32p; into pyruvate dehydrogenase phosphate in mitochondria from control and insulin-treated adipose tissue. Nature 1976, 264: 471-473.
9. Popp D.A., Kiechle F.L., Kotagal N., Jarett L. Insulin stimulation of pyruvate dehydrogenase in an isolated plasma membrane-mitochondrial mixture occurs by activation of pyruvate dehydrogenase phosphatase. J. Biol. Chem. 1980, 255: 7540-7543.
10. Rutter G.A., Diggle T.A., Denton R.M. Regulation of pyruvate dehydrogenase by insulin and polyamines within electropermeabilized fat-cells and isolated mitochondria. Biochem. J. 1992, 285: 435-439.
11. Lilley K., Zhang C., Villar-Palasi C., Larner J., Huang L. Insulin mediator stimulation of pyruvate dehydrogenase phosphatase. Arch. Biochem. Biophys. 1992, 296: 170-174.
12. Hagg S.A., Taylor S.I., Ruderman N.B. Glucose metabolism in perfused skeletal muscle. Pyruvate dehydrogenase activity in starvation, diabetes and exercise. Biochem. J. 1976, 158: 203-210.
13. Rinaudo M.T., Curto M., Bruno R., Marino C., Mostert M. Effects of insulin on pyruvate dehydrogenase in circulating lymphocytes from normal and diabetic rats. Int. J. Biochem. 1988, 20: 667-674.
14. Mondon C.E., Jones I.R., Azhar S., Hollenbech C.B., Reave G.M. Lactate production and pyruvate dehydrogenase activity in fat and skeletal muscle from diabetic rats. Diabetes 1992, 41: 1547-1554.
15. Kelley D.E., Mandarine L.J. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 1990, 86: 1999-2007.
16. Kelley D.E., Mokan M., Mandarine L.J. Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 1992, 1: 698-706.
17. Mandarino L.J., Madar Z., Kolterman O.I., Bell J.M., Olefsky J.M. Adipocyte glycogen synthase and pyruvate dehydrogenase in obese and type II diabetic subjects. Am. J. Physiol. 1986, 251 (Endocrinol. Metab. 14): E489-E49.
18. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979, 28: 1039-1045.
19. Boyüm A. Separation of leucocytes from blood and bone marrow. Scand. J. Lab. Clin. Invest. 1979, 21 (Suppl. 97): 9-109.
20. Curto M., Piccinini M., Cerutti F., Rabbone I., Mostert M., Sacchetti C., Bruno R., Rinaudo M.T. The insulin signal and its effects on the pyruvate dehydrogenase complex in circulating lymphocytes of obese children. Int. J. Biochem. 1992, 24: 831-837.
21. Teague W.M., Pettit F.H., Wu T.L., Silberman S.R., Reed L.J. Purification and properties of pyruvate dehydrogenase phosphatase from bovine heart and kidney. Biochemistry 1982, 27: 5585-5592.
22. Allred D.B., Guy D.J. Determination of coenzyme A and acetyl-CoA in tissue extracts. Anal. Biochem. 1969, 29: 293-299.
23. International Federation of Clinical Chemistry. Provisional recommendation on the theory of reference value. Chim. Clin. Acta. 1978, 87: 459-465.
24. Tango T. Estimation of normal ranges of clinical laboratory data. Statistics in Medicine 1986, 5(4): 335-346.
25. Armitage P., Berry G.D. Statistical Methods in Medical Research. Blackwell Scientific Publications, London, Oxford, 1994, p. 154-174.
26. Jarett L., Seals J.R. Pyruvate dehydrogenase activation in adipocyte mitochondria by an insulin generated mediator from muscle. Science 1979, 206: 1407-1408.
27. Seals J.R., Jarett L. Activation of pyruvate dehydrogenase by direct addition of insulin to an isolated plasma membrane/mitochondria mixture: Evidence for the generation of insulin's second messenger in a subcellular system. Proc. Natl. Acad. Sci. U.S.A. 1980, 77: 77-81.
28. Saltiel A.R., Siegel M.I., Jacobs S., Cuatrecasas P. Putative mediators of insulin action: Regulation of pyruvate dehydrogenase and adenylate cyclase activities. Proc. Natl. Acad. Sci. U.S.A. 1982, 79: 3513-3517.
29. Gottschalk W.K., Jarett L. The insulinomimetic effects of the polar head group of an insulin-sensitive glycophospholipid on pyruvate dehydrogenase in both subcellular and whole cell assays. Arch. Biochem. Biophys. 1988, 75: 175-185.
30. Cheng K., Galasko G., Huang L., Kellog J., Larner J. Studies of the insulin mediator-II Separation of two antagonistic biologically active materials from fraction II. Diabetes 1980, 29: 659-661.
31. Saltiel A., Jacobs S., Siegel M., Cuatrecasas P. Insulin stimulates the release from liver plasma membranes of a chemical modulator of pyruvate dehydrogenase. Biochem. Biophys. Res. Commun. 1981, 702: 1041-1047.
32. Saltiel A.R. Second messengers of insulin action. Diabetes Care 1990, 73: 244-256.
33. Curto M., Piccinini M., Bruno R., Mostert M., Rinaudo M.T. Insulin modulation of pyruvate dehydrogenase in human circulating lymphocytes. Int. J. Biochem. 1988, 20: 1211-1217.
34. Rabbone I., Piccinini M., Curto M., Mostert M., Gamba S., Mioletti S., Bruno R., Rinaudo M.T. Molecular effects of sulfonylurea agents in circulating lymphocytes of patients with non-insulin-dependent diabetes mellitus. Br. J. Clin. Pharmacol. 1998, 45: 291-299.
35. White M.F., Kahn C.R. The insulin signaling system. J. Biol. Chem. 1994, 269: 1-4.
36. Denton R.M., Tavare J.M. Does mitogen activated-protein kinase have a role in insulin action? The cases for and against. Eur. J. Biochem. 1995, 227: 597-611.
37. Heesom K.J., Harbeck M., Kahn C.R., Denton R.M. Insulin action on metabolism. Diabetologia 1997, 40: B3-B9.
38. Avruch J. A signal for β-cell failure. Nature 1998, 391: 846-847.
39. Vaag A., Henriksen J.E., Beck-Nielsen H. Decreased insulin activation of glycogen synthase in skeletal muscle in young nonobese. Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 1993, 89: 782-788.
40. Gulli G., Ferrannini E., Stem M., Haffner S., DeFronzo R.A. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 1992, 41: 1575-1586.
41. Eriksson J., Franssila-Kallunki A., Ekstrand A., Saloranta C., Widén E., Scalin C., Groop L. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 1989, 321: 337-343.
42. Schalin-Jäntti C., Härkönen M., Groop L.C. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 1992, 41: 598-604.
43. Larner J., Galasko G., Cheng K., DePaoli-Roach A. A., Huang L., Daggy P., Kellogg J. Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation. Science 1979, 206: 1408-1410.